The net institutional selling of ~$101M, particularly the large trims by top holder Flossbach Von Storch and Baillie Gifford, warrants caution despite the bullish analyst consensus. Monitor for upcoming pipeline catalysts (e.g., oncology data readouts) or earnings that could reverse this sentiment. The absence of insider buying weakens the bullish case from the new Assenagon position.
BNTX drugs
BNTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 11 $92.80entry
- T+1 · 3mo ago −0.06%α −0.32% · $92.74
- T+5 · 3mo ago −0.05%α +0.35% · $92.75
- T+20 · 2mo ago +5.74%α +6.80% · $98.13
- T+60 · 13d ago −2.82%α −2.68% · $90.19
How similar events traded
Executive Summary
BioNTech's 2026-Q2 institutional cluster shows a mixed picture: 5 buyers (led by a new $39.4M position from Assenagon Asset Management) accumulated $49.6M, while 6 sellers (led by Flossbach Von Storch trimming $120M and Baillie Gifford cutting $23.3M) reduced holdings by $150.8M. The net selling pressure of ~$101M from large active managers, combined with zero corroborating open-market insider buying, suggests cautious positioning ahead of the company's next pipeline catalyst or earnings update despite a bullish analyst consensus (79% buy). The cluster is dominated by active asset managers, not passive rebalancing, giving the selling signal more weight.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$101.2M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | NEW | Not reported | $39.4M | $39.4M |
| Pictet Asset Management Holding | ADD | +41% | $17.5M | $6.3M |
| Walleye Capital | DOUBLED | +245.4% | $2.9M | $2.1M |
▼ Sellers (6)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Flossbach Von Storch Se | TRIM | -39.5% | $327.1M | -$120.0M |
| Baillie Gifford & | TRIM | -32.9% | $78.4M | -$23.3M |
| Sumitomo Mitsui Trust Group | TRIM | -58.5% | $6.9M | -$3.9M |
Key Facts
- 5 institutional buyers added $49.6M in new/expanded positions in BNTX during Q2 2026
- 6 institutional sellers reduced holdings by $150.8M, led by Flossbach Von Storch trimming $120M (-39.5%) and Baillie Gifford cutting $23.3M (-32.9%)
- Net institutional selling of ~$101M across the cluster
- Assenagon Asset Management initiated a new $39.4M position, the largest buyer
- No open-market insider buying detected in the window (confluence score 36/100, institutions-only signal)
- Analyst consensus is 79% bullish (22 buy, 6 hold, 0 sell) with a $23.3B market cap
Financial Impact
5 buyers accumulated $49.6M while 6 sellers reduced holdings by $150.8M, resulting in net institutional outflow of ~$101M
Risk Factors
- Large institutional selling by top holders may signal waning conviction ahead of pipeline updates
- No insider buying to corroborate the bullish analyst consensus
- 13F data is 45+ days stale; positions may have been further adjusted since quarter-end
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BNTX-2026-Q2 |
Track record
38 reports on BNTX
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +25.10% at T+20 after the Mar 24, 2026 report. 11 of 16 went positive at some point.
Filters
- Nov 10, 20266d ago 6-K Neutral 4/10 Entry $87.21 settles Feb 8
- Nov 3, 202613d ago 6-K Neutral 5/10 No price data
- Nov 3, 202613d ago 6-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Neutral 5/10 Entry $86.92 settles Feb 1
- Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $89.13 settles Jan 27
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $86.86 settles Jan 22
- Oct 26, 202621d ago 6-K Bearish 5/10 Entry $86.86 settles Jan 22
- Oct 26, 202621d ago Press Release Bearish 6/10 Entry $86.86 settles Jan 22
- Oct 25, 202622d ago Press Release Bullish 6/10 Entry $86.86 settles Jan 22
- Oct 22, 202625d ago 6-K Neutral 5/10 Entry $89.67 settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers